Rolf Christofferson
Affiliated Researcher at Department of Women's and Children's Health; Perinatal, Neonatal and Pediatric Cardiology Research
- E-mail:
- rolf.christofferson@uu.se
- Visiting address:
- MTC-huset, Dag Hammarskjölds väg 14B, 1 tr
752 37 Uppsala - Postal address:
- Akademiska sjukhuset
751 85 UPPSALA
More information is available to staff who log in.
Publications
Recent publications
- Diagnostic Ultrasound-Guided Cutting Needle Biopsies in Neuroblastoma (2019)
- Synaptic Vesicle Protein 2 and Vesicular Monoamine Transporter 1 and 2 Are Expressed in Neuroblastoma (2019)
- Chromogranin A and neuron-specific enolase in neuroblastoma (2018)
- Resolution of infantile intestinal pseudo-obstruction in a boy (2017)
- Adhesive small bowel obstruction after laparotomy during infancy (2016)
All publications
Articles
- Diagnostic Ultrasound-Guided Cutting Needle Biopsies in Neuroblastoma (2019)
- Synaptic Vesicle Protein 2 and Vesicular Monoamine Transporter 1 and 2 Are Expressed in Neuroblastoma (2019)
- Chromogranin A and neuron-specific enolase in neuroblastoma (2018)
- Resolution of infantile intestinal pseudo-obstruction in a boy (2017)
- Adhesive small bowel obstruction after laparotomy during infancy (2016)
- Locally increased concentrations of inflammatory cytokines in an experimental intraabdominal adhesion model (2014)
- Chromogranin A In Neuroblastoma (2013)
- Local delivery of bupivacaine in the wound reduces opioid requirements after intraabdominal surgery in children (2013)
- Differentiated expression of somatostatin receptor subtypes in experimental models and clinical neuroblastoma (2011)
- Vet doktorn hur en barnrumpa ser ut? (2011)
- Metronomic administration of the drug GMX1777, a cellular NAD synthesis inhibitor, results in neuroblastoma regression and vessel maturation without inducing drug resistance (2010)
- Hirschsprungs sjukdom - ovanlig medfödd tarmsjukdom (2009)
- Regression of orthotopic neuroblastoma in mice by targeting the endothelial and tumor cell compartments (2009)
- The angiogenic growth factors HGF and VEGF in serum and plasma from neuroblastoma patients (2009)
- The Bisphosphonate Zoledronic Acid Reduces Experimental Neuroblastoma Growth by Interference with Tumor Angiogenesis (2008)
- Angiogenesis can be reduced without significant reduction of tumor growth (2007)
- The Anti-VEGF Antibody Bevacizumab Potently Reduces the Growth Rate of High-Risk Neuroblastoma Xenografts (2006)
- The selective class III/V receptor tyrosine kinase inhibitor SU11657 inhibits tumor growth and angiogenesis in experimental neuroblastomas grown in mice (2005)
- Synovial concentrations of the angiogenic peptides bFGF and VEGF do not discriminate rheumatoid arthritis from other forms of inflammatory arthritis. (2004)
- The minimal active domain of endostatin is a heparin-binding motif that mediates inhibition of tumor vascularization (2004)
- Phosphoinositide 3 kinase is critical for survival, mitogenesis and migration but not for differentiation of endothelial cells. (1999)
- "No-toouch" technique using saphenous vein harvested with its surrounding tissue for coronary artery bypass graftingmaintains an intact endothelium (1999)
- Inhibition of angiogenesis induces chromaffin differentiation and apoptosis in neuroblastoma. (1999)